Sun Pharma shares edge higher after prior 3% drop
Sun Pharmaceutical Industries shares edged higher in early trade on Sept. 2, stabilising after a nearly 3% fall in the prior session. Brokerages assessed the impact of its MFN pricing agreement with the US government.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.